Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Exercise of options and Total Voting Rights
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company announces that, pursuant to the exercise of options at nil cost under the Inspiration Healthcare Group plc Long Term Incentive Plan (the "LTIP") by an employee of the Group, a total of 6,250 new ordinary shares of 10p each in the Company ("New Ordinary Shares") have been issued and allotted by the Company.
The Company further announces that it has received notice of the exercise of options in relation to employee share options over 2,909 New Ordinary Shares issued under the Company's Sharesave Scheme.
Application has been made for an aggregate of 9,159 New Ordinary Shares to be admitted to AIM ("Admission") and such Admission is expected to become effective at 8.00am on or around 15 June 2022. The New Ordinary Shares shall rank pari passu with the existing Ordinary Shares in issue.
Total Voting Rights
For the purpose of the Disclosure Guidance and Transparency Rules of the FCA, following the above issue of New Ordinary Shares, the issued share capital of the Company will comprise 68,130,606 Ordinary Shares. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
|
Inspiration Healthcare Group plc Neil Campbell, Chief Executive Officer Jon Ballard, Chief Financial Officer |
Tel: 01455 840555 |
|
Nominated Adviser & Broker Cenkos Securities plc Stephen Keys Mark Connelly Katy Birkin Dan Hodkinson |
Tel: 0207 397 8900 |
|
Cadogan PR Alex Walters |
Tel: 07771 713608 |
About Inspiration Healthcare Group
www.inspirationhealthcaregroup.plc.uk
Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.
The Group currently consists of three companies: Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal intensive care and operating theatre equipment around the work through a network of distributors into over 75 countries. Products range from highly sophisticated capital equipment through to single use disposables all that can help improve outcomes of extremely sick patients.
In the UK and Ireland the Group offers direct sales for most of its products supported by Technical Service offering on site and return to base repair and maintenance along with 24/7 emergency hire of equipment and long term lease arrangements for its own brand products. The Group also acts as a distributor for 3 rd party companies that wish to access the NHS using the Group's sales and service expertise and knowledge of the NHS
The Group invests in growth through Research and Development holding numerous patents on its technology and has strong links with academic Key Opinion Leaders around the world and supports clinical research in the field of neonatal intensive care.
Further information on Inspiration Healthcare Group plc can be seen at www.inspirationhealthcaregroup.plc.uk